NI
KYNB

Numeric Investors’s Kyntra Bio KYNB Stock Holding History

Numeric Investors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$9.3M Sell
7,846
-136
-2% -$171K 0.07% 280
2017
Q3 		$10.7M Buy
7,982
+6,857
+610% +$7.23M 0.08% 234
2017
Q2 		$909K Buy
+1,125
New +$784K 0.01% 697

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Numeric Investors's KYNB Position: Q4 2017 in Review

Numeric Investors reduced its Kyntra Bio (KYNB) stake by 1.7% in Q4 2017, selling an estimated $171K and leaving 7,846 shares worth $9.3M. The position accounts for 0.07% of the portfolio, ranked #280.

Numeric Investors first reported a position in KYNB in Q2 2017 and has held it in 3 quarters since. The position peaked at $10.7M in Q3 2017. 187 funds tracked by Wall St. Rank hold KYNB as of Q4 2017.

  • Numeric Investors held 7,846 shares of Kyntra Bio worth $9.3M as of Q4 2017.
  • Numeric Investors sold 136 Kyntra Bio shares in Q4 2017, an estimated $171K.
  • Kyntra Bio made up 0.07% of Numeric Investors's portfolio in Q4 2017, its #280 holding.
  • Numeric Investors first reported a position in Kyntra Bio in Q2 2017 and has held it in 3 quarters since.
  • Numeric Investors's Kyntra Bio position peaked at $10.7M in Q3 2017.
  • 187 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.